“I’m looking forward to working with FrogAds.com to enhance its brand awareness,” said Anderson in a company press release.
Pamela Anderson has become one of the most recognizable names in the entertainment industry as a model, actress, mother, entrepreneur and philanthropist and has appeared on more magazine covers than any other star of her generation. The Guinness Book of World Records has even dubbed her “most downloaded,” making her perfectly suited to represent FrogAds.com’s groundbreaking online social media platform, according to the company’s report.
The company seems to be looking to leverage Anderson’s uber-popularity and the awareness that the Facebook IPO is bringing to social networking to showcase the enormous potential in monetizing its website. FrogAds.com is a free global marketplace for both classifieds and auction that enables users to post ads, photos and videos, making them visible to the global marketplace. The site has married the fundamentals of other booming websites such as eBay (NASDAQ:EBAY), Amazon.com (NASDAQ:AMZN), YouTube and Craigslist to create a one-of-a-kind advertising infrastructure.
“I couldn’t be more excited to have Pamela Anderson involved with my company as I, like the Frog, am a huge fan of Pamela, dating back to her first Playboy issue,” said Julian Spitari, Founder & CEO of FrogAds.com.
The company recently hired celebrity endorsement expert, Dayna Zegarelli, to identify a celebrity spokesperson that best identifies with the FrogAds.com brand. Zegarelli said that Anderson was the obvious choice.
Shares of FROG have been struggling to get their legs under them since the new issue began trading about two months ago. Bouncing off a low of 22 cents a share last week, the stock has moved upward tepidly today, rising 7.76% to $0.264 with 1.26 million shares changing hands with 2-1/2 hours left until the closing bell. Shares rose as high as $0.28 in early trading on the news.
FrogAds (FROG) Stock Quote and News:
Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.
According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the 
0 comments
Add your comment
Commenting is allowed only for registered users.